申请人:Bayer Pharmaceuticals Corporation
公开号:US20040157904A1
公开(公告)日:2004-08-12
The present invention relates to anilinopyrazole compounds, pharmaceutical compositions, and methods for treating diabetes and related disorders.
本发明涉及苯胺吡唑化合物、制药组合物以及治疗糖尿病及相关疾病的方法。